These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35778780)

  • 41. Clinical characteristics of eosinophilic asthma exacerbations.
    Bjerregaard A; Laing IA; Backer V; Fally M; Khoo SK; Chidlow G; Sikazwe C; Smith DW; Le Souëf P; Porsbjerg C
    Respirology; 2017 Feb; 22(2):295-300. PubMed ID: 27649851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.
    Silkoff PE; Laviolette M; Singh D; FitzGerald JM; Kelsen S; Backer V; Porsbjerg C; Girodet PO; Berger P; Kline JN; Khatri S; Chanez P; Susulic VS; Barnathan ES; Baribaud F; Loza MJ;
    Respir Res; 2016 Apr; 17():43. PubMed ID: 27107814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD.
    Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma.
    Schleich FN; Zanella D; Stefanuto PH; Bessonov K; Smolinska A; Dallinga JW; Henket M; Paulus V; Guissard F; Graff S; Moermans C; Wouters EFM; Van Steen K; van Schooten FJ; Focant JF; Louis R
    Am J Respir Crit Care Med; 2019 Aug; 200(4):444-453. PubMed ID: 30973757
    [No Abstract]   [Full Text] [Related]  

  • 45. High fractional exhaled nitric oxide and sputum eosinophils are associated with an increased risk of future virus-induced exacerbations: A prospective cohort study.
    Bjerregaard A; Laing IA; Backer V; Sverrild A; Khoo SK; Chidlow G; Sikazwe C; Smith DW; Le Souëf P; Porsbjerg C
    Clin Exp Allergy; 2017 Aug; 47(8):1007-1013. PubMed ID: 28390083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
    Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sputum biomarkers during acute severe asthma attacks in children-a case-control study.
    Ramphul M; Welsh KG; May RD; Ghebre MA; Rapley L; Cohen ES; Herath A; Monteiro W; Rousseau K; Thornton DJ; Brightling CE; Gaillard EA
    Acta Paediatr; 2022 Mar; 111(3):620-627. PubMed ID: 34773288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Airway inflammatory phenotypes of asthmatic patients].
    Zhang Y; Lin J; Su N; Liu G; Nong Y; Zhang X; Ren Z; Li X
    Zhonghua Jie He He Hu Xi Za Zhi; 2015 May; 38(5):348-51. PubMed ID: 26463485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
    Katz LE; Gleich GJ; Hartley BF; Yancey SW; Ortega HG
    Ann Am Thorac Soc; 2014 May; 11(4):531-6. PubMed ID: 24606022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-IL-5 therapies for asthma.
    Farne HA; Wilson A; Milan S; Banchoff E; Yang F; Powell CV
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD010834. PubMed ID: 35838542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex effects in the association between airway microbiome and asthma.
    Chen R; Wang L; Koch T; Curtis V; Yin-DeClue H; Handley SA; Shan L; Holtzman MJ; Castro M; Wang L
    Ann Allergy Asthma Immunol; 2020 Dec; 125(6):652-657.e3. PubMed ID: 32931909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sputum-to-serum hydrogen sulphide ratio as a novel biomarker of predicting future risks of asthma exacerbation.
    Suzuki Y; Saito J; Kikuchi M; Uematsu M; Fukuhara A; Sato S; Munakata M
    Clin Exp Allergy; 2018 Sep; 48(9):1155-1163. PubMed ID: 29758106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12 to 18 months.
    Abdel-Aziz MI; Brinkman P; Vijverberg SJH; Neerincx AH; Riley JH; Bates S; Hashimoto S; Kermani NZ; Chung KF; Djukanovic R; Dahlén SE; Adcock IM; Howarth PH; Sterk PJ; Kraneveld AD; Maitland-van der Zee AH;
    J Allergy Clin Immunol; 2021 Jan; 147(1):123-134. PubMed ID: 32353491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL; Li A; Chang AB
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma.
    Norzila MZ; Fakes K; Henry RL; Simpson J; Gibson PG
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):769-74. PubMed ID: 10712320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Associations between fungal and bacterial microbiota of airways and asthma endotypes.
    Sharma A; Laxman B; Naureckas ET; Hogarth DK; Sperling AI; Solway J; Ober C; Gilbert JA; White SR
    J Allergy Clin Immunol; 2019 Nov; 144(5):1214-1227.e7. PubMed ID: 31279011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation.
    Li N; Qiu R; Yang Z; Li J; Chung KF; Zhong N; Zhang Q
    Respir Med; 2017 Oct; 131():192-198. PubMed ID: 28947029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mepolizumab and exacerbations of refractory eosinophilic asthma.
    Haldar P; Brightling CE; Hargadon B; Gupta S; Monteiro W; Sousa A; Marshall RP; Bradding P; Green RH; Wardlaw AJ; Pavord ID
    N Engl J Med; 2009 Mar; 360(10):973-84. PubMed ID: 19264686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.
    Corren J; Pham TH; Garcia Gil E; Sałapa K; Ren P; Parnes JR; Colice G; Griffiths JM
    Allergy; 2022 Jun; 77(6):1786-1796. PubMed ID: 34913186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.